An international VOCAL initiative published in Digital Biomarkers establishes first standardized taxonomy for vocal ...

Blood neurofilament light showed promise as surrogate endpoint in neurodegenerative disease trials. Read more.

HKEY-AI2Vivo™ 1.0 supports the move from computational hypotheses to in vivo translational evidence in autoimmune and allergy research ...

The FSHD Society, SOLVE FSHD, and the FSHD Clinical Trial Research Network (FSHD CTRN) today announced significant momentum for the FSHD Industry Collaborative, including the addition of four new ...

These entrepreneurs adapt thoughtfully, make informed decisions, and build businesses with a clear sense of direction.

Health lags behind other sectors in AI adoption but the technology is already transforming research, work practices and ...

Highlights FDA End-of-Phase 2 (EOP2) meeting minutes confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA)FDA agreed ...

A study found that targeting a p300-driven pathway reversed PARP inhibitor resistance in ovarian cancer, offering a promising ...

Drug-induced organ toxicity remains a leading cause of attrition during drug development and of post-market safety ...

Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure (sustained HBsAg loss ...

Highlights FDA End-of-Phase 2 (EOP2) meeting minutes confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA)FDA agreed that a single pivotal Phase 3 trial plus confirmatory evid ...